V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270015011 | 270010837 | 1.59 | 45.8 | Adjuvant (A) | 2018-03-08 | 2018-03-09 | CARBOPLATIN + CETUXIMAB + FU | N | N | 270016059 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270015012 | 270010837 | 1.71 | 90 | Curative (C) | 2017-06-15 | 2017-06-18 | CAPECITABINE + CARBOPLATIN | 02 | N | 270016059 | FEC |
| 270015013 | 270018581 | 1.68 | 71.1 | Palliative (P) | null | 2014-02-10 | Cetuximab + CISPLATIN + FLUOROURACIL | null | N | 270017460 | CARBOPLATIN + CETUXIMAB + FU |
| 270015014 | 270010838 | null | 127.3 | Palliative (P) | 2018-04-28 | 2018-05-23 | Gemcitabine + Oxaliplatin | N | N | 270017533 | BENDAMUSTINE + BRENTUXIMAB |
| 270015015 | 270010838 | 1.79 | 65.2 | Not known (9) | null | 2014-12-11 | Carboplatin + Etoposide IV 3 day | 2 | N | 270017533 | CARBO + FLUOROURACIL |
| 270015016 | 270010839 | null | 51.5 | Curative (C) | 2015-03-03 | 2015-03-05 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | N | 270018326 | GEMCITABINE + VINORELBINE |
| 270015017 | 270010841 | 1.8 | 67.8 | Palliative (P) | 2018-11-15 | 2018-11-24 | Docetaxel 75mg/m2 (21 day) | 2 | N | 270018514 | CARBOPLATIN + RT |
| 270015018 | 270010843 | 1.8 | 48 | Disease modification (D) | 2018-08-29 | 2018-09-03 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | 270018514 | CETUXIMAB + CISPLATIN + FU |
| 270015019 | 270010843 | 1.73 | 76.9 | Curative (C) | 2017-07-27 | 2018-03-23 | CARBOPLATIN + RT | N | N | 270018514 | RALTITREXED |
| 270015020 | 270010843 | 1.55 | 56 | Curative (C) | null | 2016-11-06 | PEMBROLIZUMAB | 2 | N | 270018514 | CARBO + FLUOROURACIL |
| 270015021 | 270010844 | 1.62 | null | Curative (C) | 2016-09-28 | 2017-05-19 | CYCLOPHOSPHAMIDE + MESNA | 99 | N | 270019219 | R CODOX-M/ R IVAC |
| 270015022 | 270010844 | 1.75 | 112.3 | Curative (C) | 2018-10-06 | 2018-10-15 | Docetaxel 75mg/m2 (21 day) | N | Y | 270019219 | RALTITREXED |
| 270015023 | 270010844 | 1.72 | 64 | Curative (C) | 2018-04-04 | 2018-04-27 | CAPECITABINE + CARBOPLATIN | N | N | 270019219 | CETUXIMAB + MDG |
| 270015024 | 270010844 | 1.71 | 85 | Curative (C) | null | 2017-09-24 | IBRUTINIB | null | null | 270019219 | CISPLATIN + ETOPOSIDE + RT |
| 270015025 | 270010846 | 1.74 | 73 | Palliative (P) | 2015-04-26 | 2015-04-27 | CARBOPLATIN + RT | 2 | N | 270019701 | PACLITAXEL |
| 270015026 | 270010849 | 1.82 | null | Curative (C) | null | 2017-01-16 | Cisplatin + Docetaxel +Fluorouracil | N | null | 270019711 | DOCETAXEL |
| 270015027 | 270010850 | 1.7 | 65.8 | Palliative (P) | 2018-06-30 | 2018-07-04 | FLUOROURACIL + RT | N | N | 270019766 | CARBOPLATIN + RT |
| 270015028 | 270010855 | null | 82.4 | Palliative (P) | 2017-09-25 | 2017-09-25 | GEMCARBO | 2 | N | 270019867 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015029 | 270010856 | 1.66 | 83 | Palliative (P) | null | 2017-03-02 | ICE | N | N | 270019922 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270015030 | 270010856 | 1.75 | 122.3 | null | 2017-07-15 | 2018-01-24 | Docetaxel | 02 | N | 270019922 | CARBOPLATIN + RT |
| 270015031 | 270010856 | 1.55 | null | Palliative (P) | 2017-04-21 | 2017-04-24 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 270019922 | CAPECITABINE + CISPLATIN |
| 270015032 | 270010856 | 1.71 | 63.6 | Curative (C) | 2017-01-18 | 2017-01-18 | Carboplatin + Cetux + FU (Cycle 1) | 2 | null | 270019922 | CISPLATIN + PEMETREXED |
| 270015033 | 270010856 | 1.61 | 54.4 | Curative (C) | null | 2018-01-24 | CARBOPLATIN + RT | N | Y | 270019922 | CARBO + FLUOROURACIL |
| 270015034 | 270015060 | 1.56 | 63 | Disease modification (D) | 2015-01-19 | 2015-02-09 | ETOPOSIDE | 02 | N | 270020318 | CAPECITABINE + MITOMYCIN |
| 270015035 | 270010860 | 1.57 | null | Curative (C) | 2013-12-18 | 2013-12-22 | Cabazitaxel | N | null | 270020318 | CAPECITABINE + CISPLATIN |
| 270015036 | 270010863 | 1.76 | 65 | Curative (C) | 2015-09-19 | 2015-10-13 | CARBOPLATIN + RT | Y | N | 270020461 | CARBOPLATIN + CETUXIMAB + FU |
| 270015037 | 270015063 | 1.56 | 57.5 | null | 2018-10-18 | 2018-11-13 | PEMBROLIZUMAB | N | N | 270020461 | CARBOPLATIN + RT |
| 270015038 | 270020166 | 1.75 | 84.8 | Curative (C) | 2013-08-15 | 2013-09-24 | Cetuximab + CISPLATIN + FLUOROURACIL | Y | N | 270020876 | RALTITREXED |
| 270015039 | 270020249 | 1.59 | 82.4 | Neo-adjuvant (N) | null | 2018-06-07 | Cisplatin + Docetaxel +Fluorouracil | null | null | 270021077 | CARBOPLATIN + CETUXIMAB + FU |
| 270015040 | 270020252 | null | 67.4 | Adjuvant (A) | 2016-12-27 | 2016-12-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270021296 | CAP + RT |
| 270015041 | 270010864 | 1.71 | 65.9 | Palliative (P) | 2017-12-21 | 2017-12-25 | ETOPOSIDE | 02 | N | 270021296 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270015042 | 270010868 | null | 93 | Palliative (P) | 2017-12-29 | 2018-01-26 | PACLITAXEL | N | N | 270021311 | CARBOPLATIN + CETUXIMAB + FU |
| 270015043 | 270010868 | 1.68 | 70.9 | Palliative (P) | 2018-04-05 | 2018-04-28 | Docetaxel 75mg/m2 (21 day) | N | N | 270021311 | DOCETAXEL |
| 270015044 | 270010869 | 1.77 | 84.45 | Curative (C) | 2019-04-13 | 2019-04-27 | Lenalidomide 25mg (Cycle 1 to 25) | 2 | N | 270021726 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270015045 | 270015066 | 1.73 | 60 | Palliative (P) | null | 2018-10-08 | PABLOE | 02 | N | 270021755 | BENDAMUSTINE + RITUXIMAB |
| 270015046 | 270010878 | 1.55 | 91.6 | Palliative (P) | null | 2017-03-31 | Cisplatin + Docetaxel +Fluorouracil | null | null | 270021908 | CVD |
| 270015047 | 270017315 | 1.67 | 79.8 | Curative (C) | 2017-12-27 | 2017-12-29 | Cetuximab+Irinotecan (Cyc2 onwards) | N | N | 270021908 | RALTITREXED |
| 270015048 | 270010879 | 1.77 | 78 | Palliative (P) | 2014-09-12 | 2014-09-26 | Bevacizumab + Capecitabine | N | N | 270021950 | CISPLATIN + VINORELBINE |
| 270015049 | 270010881 | null | 70.1 | Palliative (P) | 2017-07-13 | 2017-08-28 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 270021968 | CISPLATIN + ETOPOSIDE |
| 270015050 | 270010883 | 1.62 | 87 | Curative (C) | 2017-11-15 | 2017-11-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 270022200 | TRASTUZUMAB |
| 270015051 | 270010884 | null | 86.8 | Palliative (P) | 2015-11-24 | 2015-12-29 | CARBOPLATIN + ETOPOSIDE | N | Y | 270022303 | FLUOROURACIL + MITOMYCIN + RT |
| 270015052 | 270015071 | 1.76 | 76.6 | Curative (C) | 2015-01-12 | 2015-01-18 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 270022394 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270015053 | 270010888 | 1.64 | 66.1 | Palliative (P) | 2017-05-03 | 2018-01-16 | Carboplatin + Irinotecan | 2 | N | 270022580 | CARBOPLATIN + ETOPOSIDE |
| 270015054 | 270010888 | 1.76 | 101.4 | Palliative (P) | 2016-01-27 | 2016-02-10 | Raltitrexed | N | N | 270022580 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015055 | 270019323 | 1.68 | 47.4 | Curative (C) | 2016-12-25 | 2017-01-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 270022690 | FOXTROT TRIAL |
| 270015056 | 270020092 | 1.87 | 64.5 | Disease modification (D) | 2015-06-13 | 2015-06-13 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270022690 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015057 | 270010891 | 1.62 | null | Palliative (P) | 2017-06-28 | 2017-06-28 | PACLITAXEL | N | N | 270022850 | PEMETREXED |
| 270015058 | 270010892 | 1.61 | 75.8 | Curative (C) | 2017-09-11 | 2017-09-13 | CARBOPLATIN + CETUXIMAB + FU | N | N | 270023386 | CARBOPLATIN + CETUXIMAB + FU |
| 270015059 | 270015075 | null | 52.4 | Palliative (P) | 2016-07-07 | 2016-08-24 | CARBOPLATIN + RT | N | N | 270023466 | SCOT TRIAL |
| 270015060 | 270010896 | 1.71 | null | Palliative (P) | 2017-07-01 | 2017-07-10 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 270023548 | DOCETAXEL |